FC Dismisses Roche’s Prohibition Application, Holds Apotex’s Allegations Are Justified that Patent Covering VALCYTE Is Anticipated and Obvious

READ MORE →

Stay informed. Subscribe to PCK IP’s insights for our latest commentary and updates.